For eleven years, I've handled capital equipment and supply orders for a mid-sized hospital system. I'm not the person who reads a monitor's output, and I'm not the person who signs off on the hospital's budget. I sit in the messy place between them. That's probably why I've made — and documented — 18 significant mistakes, totaling roughly $310,000 in wasted budget. Now I maintain the checklist we use to stop those mistakes from happening to other buyers.
The most damaging pattern isn't exotic. It starts with a reasonable question: What does a patient monitor measure?
Ask that question in a room full of clinicians, and you'll get a clean answer. Heart rate, SpO2, blood pressure, respiration, temperature. Add end-tidal CO2 if you buy the right module. That answer feels like certainty. It helped us compare bids for years. And it misled us almost every time.
The $310,000 Version of That Question
The first time I got burned was in 2017. We replaced the monitors on a cardiac step-down unit. I compared the requested parameters, chose the lower-priced bid, and considered my job done. The monitors measured everything the request had asked for. But they didn't integrate with the nurse call system we already used. Nobody asked me to price integration because I wasn't thinking about integration. I was thinking about measurements.
Then, in September 2022, I did it again at a larger scale—this time without that excuse.
We bought 16 monitors for two medical-surgical units. The winning vendor's base unit was $800 less per monitor than the other bid. That looked like $12,800 in savings. The monitor itself could measure every parameter in the request. The surprise wasn't the waveform quality. It was the rest of the product.
The cheaper quote didn't include network interfaces to our EMR. It didn't include the central station license, and it listed replacement SpO2 sensors under a separate contract. When we added those costs to the original quote, the cheaper purchase ended up costing $20,800 more than the other vendor's complete quote over the first 18 months. I should have known better. That's the uncomfortable part.
Why I Kept Choosing the Wrong Price
The obvious moral is to count hidden costs. The deeper reason is budget structure. Our capital budget and operating budget are managed separately. The departments that paid for integration were not the departments that approved the monitors. I got credit for a low capital quote, while the operating teams paid for accessories, service, and downtime.
Once I could see both sides, the technical question changed. 'What does a patient monitor measure?' became less useful than: what happens to those measurements? Where do they display? Who connects them to the patient chart? What does a replacement sensor cost? A patient monitor is not one product. It is a small system that begins with the screen on the wall.
It Isn't Only Patient Monitors
If you think that trap applies only to expensive capital equipment, it doesn't. I've watched the same logic play out with an electronic pipette and with an incontinence product.
Our lab once bought 30 electronic pipettes from a vendor whose price was $75 lower per unit. The saving looked like $2,250 until we found the calibration service for that vendor took 14 days and had to be shipped across the country. The pipettes worked. But the lab had to rent temporary replacements during calibration. We abandoned that practice after one annual cycle.
A similar thing happened in a routine incontinence product trial. The per-unit price was lower. Nurses used more of the trial product per patient, and the time needed for each change went up. The product cost less per item, but the care process cost more overall. A nurse manager gave me the phrase I now use in every RFP: 'I don't need a cheaper pad. I need a cheaper day.'
The Vendor Signal I Should Have Noticed Earlier
I'm not an equity analyst, so I can't speak to valuation. But I pay attention to vendor business models because their stability matters to our supply chain. GE Healthcare's Q3 2024 EBIT in the imaging segment is one example of how much of the profit in medical technology comes from recurring services and software, not the first device sale. When the 'GE Healthcare to Acquire Intelerad' press release came out, I read it as a workflow acquisition. Intelerad connects imaging workflows. A vendor that buys workflow software is telling you the value isn't only in the machine.
How We Buy Now
Our pre-purchase review no longer starts with the equipment price. Every vendor now has to answer the same five questions:
- What is the full cost to connect this device to our existing network and EMR?
- What do the sensors, cables, and consumables cost over five years?
- What is the service plan, including calibration turnaround and loaner equipment?
- Which of these categories fall into capital, operating, or clinical supply budgets?
- What training is included, and how much staff time will it take?
This checklist has caught 47 potential issues in the last 18 months. Some were pricing errors. More were workflow mismatches that would have surfaced only after installation.
This approach works well for our single-campus hospital system with a fairly stable patient population. If you are managing several locations, the model will be more complicated. The principle remains the same: the cheapest quote is not the cheapest system, and the number at the top of page one is only the beginning.
I don't blame anyone who asks 'what does a patient monitor measure?' It sounds like the right question. It is. But the complete answer doesn't fit on a spec sheet. The complete answer includes the network, the training, the service, and the replacement parts. That's where the cost of ownership lives, and that's where both good decisions and expensive surprises are made.
